Posts for the 'Avandia' Category
Avandia problems continue for GlaxoSmithKline
GlaxoSmithKline, PLC was dealt two new blows last week from the Department of Veteran Affairs and the European Medicines Agency, which will ad to their Avandia problems. The V.A. has indicated that they will be severely limiting the use of Avandia among U.S. veterans and Europe’s drug regulators announced that they will be adding tougher warnings to the drug’s label.
>>INFORMATION: Avandia Heart Problems
Actos and Avandia heart failure risk confirmed
A new study confirms that the diabetes drugs Actos and Avandia increase the risk of heart failure. Both drugs previously received a “black box” warning about congestive heart failure in June, and they have been the subject of several studies since a report in published in May found that users of Avandia face a 43% increase in the risk of heart attacks and a 64% increase in the risk of heart related deaths.
>>INFORMATION: Avandia Heart Problems
Actos better than Avandia according to recent study
According to a new study presented earlier this week, the diabetes drug Actos may be better than Avandia at controlling blood sugar and lipid levels. Over the past few months, many individuals who have been given Avandia to treat their type 2 diabetes, have been concerned about the safety of the drug following reports which indicate Avandia may increase the risk of heart attacks and heart related deaths. If Actos is more effective than Avandia, more individuals may decide that the risk of Avandia heart attacks outweighs the potential benefits provided by the diabetes drug.
>>INFORMATION: Avandia heart attack risk
Avandia recall should be considered according to researchers
Two studies and an editorial published yesterday in the Journal of the American Medical Association (JAMA), provide compelling evidence which researchers indicate may warrant an Avandia recall. One study confirmed earlier findings that Avandia increases the risk of heart attacks, while a second study found that Actos, an alternative drug for treatment of type 2 diabetes, may actually reduces the risk of heart attacks, strokes and death.
>>INFORMATION: Avandia Heart Side Effects
Actos and Avandia Black Box Warning for risk of heart failure
The FDA announced late yesterday that the manufacturers of Avandia and Actos have agreed to add a stronger black box warning regarding the increased risk of heart failure. The announcement comes two months after federal regulators testified at a congressional hearing that they would be requesting the drug makers add such a warning. Read the rest of this entry »
FDA Panel does not recommend Avandia recall
Monday an FDA advisory panel reviewed whether there should be an Avandia recall, but recommended that the type 2 diabetes drug remain on the market with stronger warnings regarding the heart risks. Although the panel voted 20 to 3 that Avandia does increase the risk of heart attacks, they did not believe that sufficient evidence exists at this time to recommend a recall.
>>PRIOR POST(7/26/07): Avandia Recall to be reviewed by FDA
Avandia recall to be reviewed by FDA
The FDA will hold advisory panel meetings next week to review whether there should be an Avandia recall following reports which indicate users of the diabetes drug face a 43% increased risk of heart attacks. Although the FDA is not required to follow the advise of their advisory panels, they usually do.
>>INFORMATION: Avandia side effects
Comparing Avandia, Actos and older diabetes drugs
Concerned about the possible increased risk of heart attacks and death recently associated with Avandia, users may find useful information in two reports which compare Avandia with Actos and other diabetes medications. One report indicates that Actos may not carry the same heart attack risk as Avandia, and the other indicates that cheaper, older diabetes drugs may be safer and just as effective.
>>INFORMATION: Avandia problems
Reports of Avandia heart attacks increase sharply
According to the Associated Press, the number of reported heart problems associated with Avandia has jumped significantly since a study published May 21 in the New England Journal of Medicine demonstrated an increased risk of heart attacks and death associated with the diabetes drug. With knowledge of the increased risk, doctors are more aware of the cause of their patient’s heart problems and those who suffered an injury are now turning to Avandia lawsuits to pursue compensation .
>>INFORMATION: Avandia heart attack risk
Debate about Avandia heart risks continues
Yesterday at the annual meeting of the American Diabetes Association in Chicago, the debate about heart risks associated with Avandia was a main topic. Concerns have been widespread among diabetes patients and doctors about an increased risk of heart attacks and heart related death since a study was published last month in the New England Journal of Medicine.
INFORMATION: Avandia heart problems
